MPM Oncology Impact Management LP, 10% Owner at Werewolf Therapeutics, Inc. (HOWL), bought 4,722,742 shares at $16.00 ($3.9M) on 2021-05-04, disclosed to the SEC on 2021-05-06.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 4,477,742 | $0 | 0.0% |
| 2 | $16.00 | 245,000 | $3.9M | 100.0% |
| Total | $0.83 avg | 4,722,742 | $3.9M | 100% |
| Filing → |
| ITOS | SELL | 2021-04-13 | $6K | — | Filing → |
| ITOS | SELL | 2021-04-09 | $2.5M | — | Filing → |
| CGEM | BUY | 2021-01-14 | $6.3M | — | Filing → |